Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function

Abstract
No abstract available
Funding Information
  • Howard Hughes Medical Institute (HL 089027, HL 095571, CA BCRP 14IB-0039)
  • National Institutes of Health (HL 089027, HL 095571, CA BCRP 14IB-0039)
  • Burroughs Wellcome Fund (HL 089027, HL 095571, CA BCRP 14IB-0039)

This publication has 73 references indexed in Scilit: